HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

(trans)-Isomer 3,4- Dichloro- N- methyl- N- (2- (1- pyrrolidinyl)- cyclohexyl)- benzeneacetamide

A non-peptide, kappa-opioid receptor agonist which has also been found to stimulate the release of adrenocorticotropin (ADRENOCORTICOTROPIC HORMONE) via the release of hypothalamic arginine vasopressin (ARGININE VASOPRESSIN) and CORTICOTROPIN-RELEASING HORMONE. (From J Pharmacol Exp Ther 1997;280(1):416-21)
Also Known As:
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Mesylate, (trans)-(+)-Isomer; 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Mesylate, (trans)-(+-)-Isomer; 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monohydrochloride, (trans)-(+-)-Isomer,; 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monomethanesulfonate, (trans)-(+)-Isomer; 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monomethanesulfonate, (trans)-(+-)-Isomer; 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monomethanesulfonate, (trans)-Isomer; 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (1R-cis)-Isomer; 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (1S-cis)-Isomer; 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(+-)-Isomer; 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(-)-Isomer; U-50,488H; U-50488; U-50488H; U50488H; trans-3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide; trans-3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide Hydrochloride; U 50,488H; U 50488; U 50488H; U50,488H; U50488; Benzeneacetamide, 3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-, (trans)-Isomer
Networked: 201 relevant articles (14 outcomes, 24 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Li, Juan: 15 articles (05/2020 - 09/2007)
2. Fan, Rong: 13 articles (05/2020 - 09/2007)
3. Pei, Jian-Ming: 9 articles (01/2016 - 04/2006)
4. Wang, Yue-Min: 9 articles (01/2016 - 04/2006)
5. Pei, Jianming: 8 articles (05/2020 - 01/2011)
6. Guo, Hai-Tao: 8 articles (01/2016 - 04/2006)
7. Wang, Yuemin: 7 articles (05/2020 - 01/2011)
8. Kaye, Alan David: 7 articles (09/2013 - 04/2009)
9. Xia, Qiang: 7 articles (08/2010 - 01/2003)
10. Feng, Na: 6 articles (05/2020 - 03/2013)

Related Diseases

1. Fibrosis (Cirrhosis)
2. Brain Ischemia (Cerebral Ischemia)
3. Cognitive Dysfunction
4. Pain (Aches)
5. Pulmonary Hypertension

Related Drugs and Biologics

1. kappa Opioid Receptors (kappa Opioid Receptor)
2. Opioid Analgesics (Opioids)
3. Opioid Receptors (Opioid Receptor)
4. Morphine (MS Contin)
5. Isoproterenol (Isoprenaline)
6. Salts
7. Ammonium Compounds
8. Narcotic Antagonists (Opioid Antagonists)
9. Dynorphins (Dynorphin)
10. Calcium-Calmodulin-Dependent Protein Kinase Type 2

Related Therapies and Procedures

1. Analgesia
2. Intravenous Administration
3. Injections
4. Ligation
5. Intradermal Injections